Search research articles
Contact Us
Filters
Showing results (61-70 of 92) with videos related to
Page
of 10
Sort By:
Cancer Immunology Research
|
September 16, 2017
Customized Viral Immunotherapy for HPV-Associated Cancer
Matthew J Atherton, Kyle B Stephenson, Jonathan Pol, et al.
Molecular Therapy Oncolytics
|
February 22, 2021
Combining vanadyl sulfate with Newcastle disease virus potentiates rapid innate immune-mediated regression with curative potential in murine cancer models
Thomas M McAusland, Jacob P van Vloten, Lisa A Santry, et al.
Oncolytic Virotherapy
|
December 13, 2018
Development and applications of oncolytic Maraba virus vaccines
Jonathan G Pol, Matthew J Atherton, Byram W Bridle, et al.
Science Translational Medicine
|
January 5, 2018
Neoadjuvant oncolytic virotherapy before surgery sensitizes triple-negative breast cancer to immune checkpoint therapy
Marie-Claude Bourgeois-Daigneault, Dominic Guy Roy, Amelia Sadie Aitken, et al.
Molecular Therapy Oncolytics
|
July 6, 2019
Assessing the Completeness of Reporting in Preclinical Oncolytic Virus Therapy Studies
Dean A Fergusson, Neil L Wesch, Garvin J Leung, et al.
Hematological Oncology
|
May 8, 2021
Safety and efficacy of autologous whole cell vaccines in hematologic malignancies: A systematic review and meta-analysis
Donald J Bastin, Sarwat T Khan, Joshua Montroy, et al.
Journal of Cancer Research and Clinical Oncology
|
February 8, 2021
Personalized oncology and BRAF<sup>K601N</sup> melanoma: model development, drug discovery, and clinical correlation
Brian A Keller, Brian J Laight, Oliver Varette, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 15, 2010
A high-throughput pharmacoviral approach identifies novel oncolytic virus sensitizers
Jean-Simon Diallo, Fabrice Le Boeuf, Frances Lai, et al.
Pharmaceuticals (Basel, Switzerland)
|
May 27, 2023
Engineering Rapalog-Inducible Genetic Switches Based on Split-T7 Polymerase to Regulate Oncolytic Virus-Driven Production of Tumour-Localized IL-12 for Anti-Cancer Immunotherapy
Nikolas T Martin, Mathieu J F Crupi, Zaid Taha, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 26, 2008
Chemical targeting of the innate antiviral response by histone deacetylase inhibitors renders refractory cancers sensitive to viral oncolysis
Thi Lien-Anh Nguyên, Hesham Abdelbary, Meztli Arguello, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 92) with videos related to
Sort By:
Page
of 10
Cancer Immunology Research
|
September 16, 2017
Customized Viral Immunotherapy for HPV-Associated Cancer
Matthew J Atherton, Kyle B Stephenson, Jonathan Pol, et al.
Molecular Therapy Oncolytics
|
February 22, 2021
Combining vanadyl sulfate with Newcastle disease virus potentiates rapid innate immune-mediated regression with curative potential in murine cancer models
Thomas M McAusland, Jacob P van Vloten, Lisa A Santry, et al.
Oncolytic Virotherapy
|
December 13, 2018
Development and applications of oncolytic Maraba virus vaccines
Jonathan G Pol, Matthew J Atherton, Byram W Bridle, et al.
Science Translational Medicine
|
January 5, 2018
Neoadjuvant oncolytic virotherapy before surgery sensitizes triple-negative breast cancer to immune checkpoint therapy
Marie-Claude Bourgeois-Daigneault, Dominic Guy Roy, Amelia Sadie Aitken, et al.
Molecular Therapy Oncolytics
|
July 6, 2019
Assessing the Completeness of Reporting in Preclinical Oncolytic Virus Therapy Studies
Dean A Fergusson, Neil L Wesch, Garvin J Leung, et al.
Hematological Oncology
|
May 8, 2021
Safety and efficacy of autologous whole cell vaccines in hematologic malignancies: A systematic review and meta-analysis
Donald J Bastin, Sarwat T Khan, Joshua Montroy, et al.
Journal of Cancer Research and Clinical Oncology
|
February 8, 2021
Personalized oncology and BRAF<sup>K601N</sup> melanoma: model development, drug discovery, and clinical correlation
Brian A Keller, Brian J Laight, Oliver Varette, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 15, 2010
A high-throughput pharmacoviral approach identifies novel oncolytic virus sensitizers
Jean-Simon Diallo, Fabrice Le Boeuf, Frances Lai, et al.
Pharmaceuticals (Basel, Switzerland)
|
May 27, 2023
Engineering Rapalog-Inducible Genetic Switches Based on Split-T7 Polymerase to Regulate Oncolytic Virus-Driven Production of Tumour-Localized IL-12 for Anti-Cancer Immunotherapy
Nikolas T Martin, Mathieu J F Crupi, Zaid Taha, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 26, 2008
Chemical targeting of the innate antiviral response by histone deacetylase inhibitors renders refractory cancers sensitive to viral oncolysis
Thi Lien-Anh Nguyên, Hesham Abdelbary, Meztli Arguello, et al.
Page
of 10